Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Trans Code Therapeutics Appoints John Tattory As Interim Chief Financial Officer
PUBLIC · RNAZSep 10, 2026•about 3 hours ago
Position
Chief Financial Officer
Company
TransCode Therapeutics
John Tattory
BostonBiotechnologyHealth CareMedicalTherapeutics
Description
TransCode Therapeutics announced the retirement of its Chief Financial Officer, Tom Fitzgerald, effective immediately. John Tattory will take over as Interim Chief Financial Officer, bringing over 25 years of financial and operational experience to the role.
Company Information
Company
TransCode Therapeutics
Location
Boston, Massachusetts, United States
About
TransCode is an RNA oncology company created on the belief that cancer can be more effectively treated using RNA therapeutics. Using its proprietary iron oxide nanoparticle delivery platform, the company has created a portfolio of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient outcomes. The company’s lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which is believed to cause approximately 90% of all cancer deaths totaling over nine million per year worldwide. Another of the company’s drug candidates, TTX-siPDL1, focuses on treating tumors by targeting a protein called Programmed death-ligand 1 (PD-L1). TransCode also has three cancer-agnostic programs: TTX-RIGA, an RNA–based agonist of the retinoic acid-inducible gene I designed to drive an immune response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9–based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines designed to activate cytotoxic immune responses against tumor cells.
Don't miss TransCode Therapeutics's next move
Get an email the moment TransCode Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.
BostonBiotechnologyHealth CareMedicalTherapeutics